NEW YORK, September 30, 2015 /PRNewswire/ --
ACI Association has initiated research coverage on the following
equities: Two Harbors Investments Corp (NYSE: TWO),
Hudson City Bancorp, Inc. (NASDAQ: HCBK), Novavax,
Inc. (NASDAQ: NVAX), Opko Health Inc (NYSE: OPK),
Exelixis, Inc. (NASDAQ: EXEL). On Tuesday, September 29, 2015, Nasdaq ended at
4517.32, down 0.59%, Dow Jones advanced 0.30%, to finish the day at
16049.13, and the S&P closed at 1884.09, up 0.12%. Register for
your complimentary reports at the links given
below.
Two Harbors Investment Corp
Two Harbors Investment Corp's stock edged lower by 1.35% to
close Tuesday's session at USD 8.79.
The company's shares oscillated between USD
8.75 and USD 8.99. The stock recorded a trading volume of
4.64 million shares, which was above its 50-day daily average
volume of 2.50 million shares. Over the last three days, Two
Harbors Investment Corp's shares have declined by 8.15% and in the
past one week it has moved down 7.76%. Furthermore, over the last
three months, the stock has lost 9.75% and in the past six months,
the shares have shed 17.23%. Two Harbors Investment Corp has a
current dividend yield of 11.67%. Further, the company is trading
at a price to earnings ratio of 6.81. This compares to a historical
PE ratio of 21.94. Sign up and read the free notes on TWO at:
http://www.aciassociation.com/TWO.pdf
Hudson City Bancorp Inc
The stock of Hudson City Bancorp Inc lost 0.73% to close
Tuesday's session at USD 9.50. The
shares of the company moved in the range of USD 9.45 and USD
9.76. A trading volume of 4.26 million shares was recorded,
which was greater than its 150-day daily average volume of 3.87
million shares. Over the last five days, Hudson City Bancorp Inc's
shares have advanced 2.48% and in the past one month, it has gained
a momentum of 0.53%. However, over the last three months, the stock
has declined 3.85% and in the past six months, the shares have
registered a loss of 9.35%. Hudson City Bancorp Inc has a current
dividend yield of 1.67%. Further, the company is trading at a price
to earnings ratio of 41.30 and the stock is at a price to book
ratio of 1.04. This compares to a historical PE ratio of 32.12. The
historical PB ratio is near to 1.12. Further, the stock is trading
at a price to cash flow ratio of 142.46 and price to sales ratio of
4.24. Register for free on ACI Association and access the latest
research on HCBK at:
http://www.aciassociation.com/HCBK.pdf
Novavax Inc
Novavax Inc's stock decreased by 21.35% to close Tuesday's
session at USD 6.41. The company's
shares fluctuated in the range of USD
6.25 and USD 8.42. A total of
26.51 million shares exchanged hands, which surpassed its 50-day
daily average volume of 5.80 million shares. Over the last three
days Novavax Inc's shares have declined by 30.25% and in the past
one week it has moved down 34.39%. Furthermore, over the last three
months, the stock has lost 42.46% and in the past six months, the
shares have shed 22.49%. The stock is at a price to book ratio of
4.44. The historical PB ratio is near to 6.17. Additionally, the
stock is trading at a price to sales ratio of 44.46. The complete
research on NVAX is available for free at:
http://www.aciassociation.com/NVAX.pdf
OPKO Health Inc
OPKO Health Inc's stock slipped by 1.86% to close Tuesday's
session at USD 8.42. The company's
shares oscillated between USD 8.26 and USD
8.99. The stock recorded a trading volume of 8.87 million
shares, which was above its 50-day daily average volume of 5.68
million shares. Over the last five days, OPKO Health Inc's shares
have declined by 13.64% and in the past one month, it has lost
24.28%. In addition, over the last three months, the stock has lost
47.64% and year to date, the shares have shed 15.72%. The stock is
at a price to book ratio of 12.52. The historical PB ratio is near
to 5.13. Additionally, the stock is trading at a price to sales
ratio of 32.30. Free in-depth research on OPK is available at:
http://www.aciassociation.com/OPK.pdf
Exelixis Inc
Exelixis Inc's stock declined 1.24% to close Tuesday's session
at USD 5.59. The share price
vacillated between USD 5.48 and USD
6.08. The stock recorded a trading volume of 6.13 million
shares, which was above its 52-week average volume of 4.30 million
shares. Over the last three days Exelixis Inc's shares have
declined by 9.84% and in the past one week it has moved down
10.42%. However, in the last six months, the stock has gained
117.51% and year to date, the shares have picked up 288.19%. On a
compounded total return basis, the company has returned 120.08% in
the last half a year, and 265.36% in the past one year.
Additionally, the stock is trading at a price to sales ratio of
40.62. The complimentary notes on EXEL can be downloaded in PDF
format at:
http://www.aciassociation.com/EXEL.pdf
About ACI Association:
Active Charter Investors Association ("ACI Association")
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
equities listed on NYSE and NASDAQ and micro-cap stocks. ACI
Association has two distinct and independent departments. One
department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ACI Association has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein. The information in this release has been
sourced from a third party data base.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor
(collectively referred to as the "Publishers") are not responsible
for any error which may be occasioned at the time of printing of
this document or any error, mistake or shortcoming. No liability is
accepted by the Publishers whatsoever for any direct, indirect or
consequential loss arising from the use of this document. The
Publishers expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, the Publishers do not (1) guarantee the accuracy,
timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The
included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ACI Association nor any party affiliated
with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our
report(s), read our disclosures, or for more information, visit
http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.aciassociation.com